Federal Panel Recommends Every Child should Receive Rotavirus Vaccination
Rotavirus is one of the most common causes of childhood illness. Often referred to as “stomach flu,” rotavirus causes at least 55,000 U.S. children to be hospitalized annually for dehydration resulting from uncontrollable vomiting and diarrhea.
Fifty to 60 of these children will die. Most American children come down with the ailment repeatedly by age 5 and recover at home. They gradually gain immunity, usually by the time they enter first grade. In developing countries with poor access to health care, however, hundreds of thousands of babies die from rotavirus every year.
To combat this intestinal germ, a federal advisory panel recommended to the FDA that every healthy newborn in the U.S. be vaccinated for rotavirus in the first months of life. Babies should be given vaccine at age 2 months, 4 months, and 6 months, the panel recommends. The oral vaccine won approval from the FDA on February 3. Some doctors already have supplies on hand. The panel’s recommendation becomes policy when adopted by the Center for Disease Control and Prevention (CDC), which is expected to happen.
Seven years earlier, a rotavirus vaccine with withdrawn from the market after causing potentially life-threatening intestinal blockages in some babies. The new vaccine produced by Merck Pharmaceuticals has been rigorously tested for safety. RotaTeq, the improved vaccine, was tested in about 70,000 babies in 11 countries in one of the largest vaccine trials ever.
RotaTeq “generally appears to have a better safety profile than the earlier vaccine,” said Umesh Parashar, a medical epidemiologist at the CDC. He adds that it will continue to be scrutinized and hopefully confirm the absence of risk. The new vaccine will be one of the most expensive vaccines ever marketed. Doctors are expected to charge $300 for the series of three oral vaccines.
RotaTeq contains live, but weakened strains of the virus. The vaccine is designed to build immunity without causing a baby to become ill.
Fifty to 60 of these children will die. Most American children come down with the ailment repeatedly by age 5 and recover at home. They gradually gain immunity, usually by the time they enter first grade. In developing countries with poor access to health care, however, hundreds of thousands of babies die from rotavirus every year.
To combat this intestinal germ, a federal advisory panel recommended to the FDA that every healthy newborn in the U.S. be vaccinated for rotavirus in the first months of life. Babies should be given vaccine at age 2 months, 4 months, and 6 months, the panel recommends. The oral vaccine won approval from the FDA on February 3. Some doctors already have supplies on hand. The panel’s recommendation becomes policy when adopted by the Center for Disease Control and Prevention (CDC), which is expected to happen.
Seven years earlier, a rotavirus vaccine with withdrawn from the market after causing potentially life-threatening intestinal blockages in some babies. The new vaccine produced by Merck Pharmaceuticals has been rigorously tested for safety. RotaTeq, the improved vaccine, was tested in about 70,000 babies in 11 countries in one of the largest vaccine trials ever.
RotaTeq “generally appears to have a better safety profile than the earlier vaccine,” said Umesh Parashar, a medical epidemiologist at the CDC. He adds that it will continue to be scrutinized and hopefully confirm the absence of risk. The new vaccine will be one of the most expensive vaccines ever marketed. Doctors are expected to charge $300 for the series of three oral vaccines.
RotaTeq contains live, but weakened strains of the virus. The vaccine is designed to build immunity without causing a baby to become ill.
Comments
Post a Comment